We are live on
!
Find out more
SM
Sabby Management Portfolio holdings
AUM
$111M
1-Year Est. Return
74.4%
This Fund
S&P 500
This Quarter
Est. Return
+19.05%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$1.5B
AUM Growth
–
Cap. Flow
+$184M
Cap. Flow
% of AUM
12.29%
Top 10 Holdings %
Top 10 Hldgs %
43.16%
Holding
169
New
166
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AEGR
Aegerion Pharmaceuticals
AEGR
|
+$31.5M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$16.3M |
| 3 |
AbbVie
ABBV
|
+$15.6M |
| 4 |
Zoetis
ZTS
|
+$14.9M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$12.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.18% |
| 2 | Healthcare | 10.75% |
| 3 | Energy | 0.07% |
Similar funds
IWA
BFA
WPWM
BCM
ZS
KC
FI
CIM
Sabby Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Sabby Management, which disclosed 169 positions worth $1.5B. Its ten largest holdings account for 43% of the portfolio.
Its largest position is Aegerion Pharmaceuticals: 593,862 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, followed by Healthcare and Energy.
- Sabby Management's largest Q2 2013 buy was Aegerion Pharmaceuticals: 593,862 shares worth $37.6M.
- Sabby Management's ten largest holdings make up 43% of its $1.5B portfolio in Q2 2013.
- Sabby Management disclosed 169 positions in Q2 2013, its first 13F filing on record.
Based on Sabby Management's 13F filing for Q2 2013, filed 14 Aug 2013.